Iteos Therapeutics Correlations

ITOS Stock  USD 10.15  0.02  0.20%   
The current 90-days correlation between Iteos Therapeutics and Arcus Biosciences is 0.29 (i.e., Modest diversification). The correlation of Iteos Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Iteos Therapeutics Correlation With Market

Significant diversification

The correlation between Iteos Therapeutics and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iteos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Iteos Stock please use our How to Invest in Iteos Therapeutics guide.

Moving together with Iteos Stock

  0.71VRDN Viridian TherapeuticsPairCorr
  0.73VTYX Ventyx BiosciencesPairCorr
  0.62NUVL NuvalentPairCorr
  0.66ACLX ArcellxPairCorr
  0.61SEER Seer IncPairCorr
  0.63PTAIF PT Astra International Earnings Call This WeekPairCorr
  0.7EC Ecopetrol SA ADRPairCorr
  0.64GE GE AerospacePairCorr

Moving against Iteos Stock

  0.4CERT CertaraPairCorr
  0.61MCD McDonaldsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
KYMRNRIX
KYMRANNX
NRIXANNX
NRIXRLAY
KYMRRLAY
RLAYANNX
  
High negative correlations   
GPCRANNX
KYMRGPCR
RLAYGPCR
NRIXGPCR
CCCCGPCR
GPCRRCUS

Risk-Adjusted Indicators

There is a big difference between Iteos Stock performing well and Iteos Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Iteos Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Iteos Therapeutics Corporate Management

Matthew GallChief OfficerProfile
Matthew MBAChief OfficerProfile
Ryan BakerHead RelationsProfile
Joanne MDChief OfficerProfile
Adi OsovskyExecutive LegalProfile